Chemical control of phospholipid distribution across bilayer membranes

Medicinal Research Reviews

Volumn 22, Issue 3, 2002, Pages 251-281

  Middleton Boon, J ^a   Smith, Bradley D ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Erythrocyte membrane; Flip flop; Phospholipid asymmetry; Phospholipid translocation

Indexed keywords

AMPHOPHILE; ANESTHETIC AGENT; LOCAL ANESTHETIC AGENT; MEMBRANE PROTEIN; PEPTIDE; PHOSPHOLIPID;

ANIMAL CELL; BACTERIAL MEMBRANE; BILAYER MEMBRANE; CROSS LINKING; CYTOSKELETON; ELECTROPORATION; ERYTHROCYTE MEMBRANE; EUKARYOTE; HUMAN; HUMAN CELL; NONHUMAN; PH; PHAGOCYTOSIS; PHOSPHOLIPID BILAYER; PHOSPHOLIPID TRANSFER; PROTEIN ANALYSIS; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; ERYTHROCYTE MEMBRANE; HUMANS; LIPID BILAYERS; PHOSPHOLIPIDS;

EID: 0036238014     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10009     Document Type: Review

References (238)

1. Inside-outside transitions of phospholipids in vesicle membranes
2. Use of phospholipid exchange protein to measure inside-outside transposition in phosphatidylcholine liposomes
3. Asymmetric exchange of vesicle phospholipids catalyzed by the phosphatidylcholine exchange protein: Measurement of inside-outside transitions
4. Transbilayer diffusion of phospholipids: Dependence on headgroup structure and acyl chain length
5. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes
6. Identification and purification of aminophospholipid flippases
7. Measurement of outward translocation of phospholipids across human erythrocyte membrane
8. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells
9. Reconstitution of a phospholipid flippase from rat liver microsomes
10. Assembly of the endoplasmic reticulum phospholipid bilayer: Transporters for phosphatidylcholine and metabolites
11. Protein-mediated phospholipid translocation in the endoplasmic reticulum with a low lipid specificity
12. Ultrafast glycerophospholipid-selective transbilayer motion mediated by a protein in the endoplasmic reticulum membrane
13. Reconstitution of yeast microsomal lipid flip-flop using endogenous aminophospholipids
14. Specific proteins are required to translocate phosphatidylcholine bidirectionally across the endoplasmic reticulum
15. Transmembrane movement of phosphatidylcholine in mitochondrial outer membrane vesicles
16. Rapid transmembrane movement of newly synthesized phospholipids during membrane assembly
17. 6-NBD-labeled phospholipids across the inner membrane of Escherichia coli
18. Transbilayer movement of fluorescent phospholipids in Bacillus megaterium membrane vesicles
19. Reactivity of the human erythrocyte membrane to sodium trinitrobenzenesulphonate
20. The asymmetric arrangement of phospholipids in the human erythrocyte membrane
21. The reaction of chemical probes with the erythrocyte membrane
22. Penetration of 2,4,6-trinitrobenzenesulfonate into human erythrocytes: Consequences for studies on phospholipid asymmetry
23. The proteins of erythrocyte membranes: Where are they?
24. Asymmetrical lipid bilayer structure for biological membranes
25. Phosphatidylethanolamine: Differential labelling in intact cells and cell ghosts of human erythrocytes by a membrane-impermeable reagent
26. Amidination of the outer and inner surfaces of the human erythrocyte membrane
27. Localization of red cell membrane constituents
28. The asymmetric distribution of phospholipids in the human red cell membrane: A combined study using phospholipases and freeze-etch electron microscopy
29. The use of phospholipases in the determination of asymmetric phospholipid distribution in membranes
30. Fluorescence assay for phospholipid membrane asymmetry
31. Transverse membrane asymmetry in model phospholipid bilayers: NBD-phosphatidylethanolamine and the separation of flip from flop
32. Continuous measurement of rapid transbilayer movement of a pyrene-labeled phospholipid analogue
33. The use of N-(7-nitrobenz-2-oxa-1,3-diazole-4-yl)-labeled lipids in determining transmembrane lipid distribution
34. Dynamics of membrane penetration of the fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) group attached to an acyl chain of phosphatidylcholine
35. Membrane bilayer balance and erythrocyte shape: A quantitative assessment
36. Incorporation and translocation of aminophospholipids in human erythrocytes
37. Biological membranes as bilayer couples: A molecular mechanism of drug-erythrocyte interactions
38. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
39. Phosphatidylserine exposure and phagocytosis of apoptotic cells
40. Changes in membrane phospholipid distribution during platelet activation
41. Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: Quantitative assessment of outer-leaflet lipid by prothrombinase complex formation
42. Hydrogen peroxide oxidation induces the transfer of phospholipids from the membrane into the cytosol of human erythrocytes
43. Role of membrane lipid distribution in chlorpromazine-induced shape change of human erythrocytes
44. Protein kinase C as a measure of transbilayer phosphatidylserine asymmetry
45. Reaction of human serum albumin and human erythrocytes with tritiated 2,4,6-trinitrobenzenesulfonic acid and tritiated picryl chloride
46. Asymmetrical distribution of phospholipids in the membrane of Bacillus megaterium
47. Experimental alteration of phospholipid-protein interactions within the human erythrocyte membrane: Dependence on glycolytic metabolism
48. Evidence for an asymmetric distribution of phospholipids in the human erythrocyte membrane
49. Organization of phospholipids in human red cell membranes as detected by the action of various purified phospholipases
50. Lipid asymmetry in membranes
51. Phospholipid asymmetry in human erythrocyte ghosts
52. Transmembrane redistribution of phospholipids of the human red cell membrane during hypotonic lysis
53. Transbilayer distribution and mobility of phosphatidylinositol in human red blood cells
54. Asymmetric distribution of phosphoinositides and phosphatidic acid in the human erythrocyte membrane
55. Trans-bilayer distribution of phosphatidylinositol 4,5-bisphosphate and its role in the changes of lipid asymmetry in the human erythrocyte membrane
56. Asymmetry and transposition rates of phosphatidylcholine in rat erythrocyte ghosts
57. Topological asymmetry of phospholipid metabolism in rat erythrocyte membranes: Evidence for flip-flop of lecithin
58. Transbilayer phospholipid asymmetry in Plasmodium knowlesi-infected host cell membrane
59. Phospholipid localization in the plasma membrane of Friend erythroleukemic cells and mouse erythrocytes
60. Enzyme and phospholipid asymmetry in liver microsomal membranes
61. Evidence against phospholipid asymmetry in intracellular membranes from liver
62. Asymmetry of the phospholipid bilayer of rat liver endoplasmic reticulum
63. Phospholipid asymmetry in rough -and smooth-endoplasmic-reticulum membranes of untreated and phenobarbital-treated rat liver
64. Asymmetric distribution of phospholipids in the inner membrane of beef heart mitochondria
65. Lipids of mitochondria
66. Reaction of amino-phospholipids of the inner mitochondrial membrane with fluorodinitrobenzene and trinitrobenzenesulfonate
67. Transverse asymmetry of phospholipids in subcellular membranes of rat liver
68. Lipid topology and physical properties of the outer mitochondrial membrane of the yeast, Saccharomyces cerevisiae
69. Phospholipid asymmetry of the outer membrane of rat liver mitochondria: Evidence for the presence of cardiolipin on the outside of the outer membrane
70. Lipids of synaptic vesicles: Relevance to the mechanism of membrane fusion
71. Asymmetry of lipid organization in cholinergic synaptic vesicle membranes
72. Phospholipid translocation from the outer to the inner leaflet of synaptic vesicle membranes isolated from the electric organ of Japanese electric ray Narke japonica
73. Localization of the amino phospholipids in sarcoplasmic reticulum membranes revealed by trinitrobenzenesulfonate and fluorodinitrobenzene
74. Phospholipid asymmetry in the endoplasmic reticulum of castor bean endosperm
75. Transbilayer phospholipid asymmetry and its maintenance in the membrane of influenza virus
76. Asymmetric distribution of phosphatidylethanolamine in the membrane of vesicular stomatitis virus
77. Lipid organization of the membrane of vesicular stomatitis virus
78. Compositional asymmetry and transmembrane movement of phosphatidylcholine in vesicular stomatitis virus membranes
79. Phospholipid asymmetry in Semliki Forest virus grown on baby hamster kidney (BHK-21) cells
80. Membrane phospholipid asymmetry in Semliki Forest virus grown in BHK cells
81. Phospholipid asymmetry in plasma membrane vesicles derived from BHK cells
82. Phospholipid asymmetry in LM cell plasma membrane derivatives: Polar head group and acyl chain distributions
83. Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells
84. Lipid composition and phospholipid asymmetry of membranes from a Schwann cell line
85. Lipid transfer proteins as a tool in the study of membrane structure: Inside-outside distribution of the phospholipids in the protoplasmic membrane of Micrococcus lysodeikticus
86. The distribution of lipids in the protoplast membranes of Bacillus subtilis: A study with phospholipase C and trinitrobenzenesulphonic acid
87. Membrane phospholipid asymmetry in Bacillus amyloliquefaciens
88. Differential reaction of cell membrane phospholipids and proteins with chemical probes
89. Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12
90. Structure and synthesis of a lipid-containing bacteriophage: Properties of the structural proteins and distribution of the phospholipid
91. Asymmetric distribution of arachidonic acid in the plasma membrane of human platelets: A determination using purified phospholipases and a rapid method for membrane isolation
92. Estimation of the phospholipid distribution in the human platelet plasma membrane based on the effect of phospholipase A2 from Naja nigricollis
93. Changes of the compositional asymmetry of phospholipids associated to the increment in the membrane surface potential
94. Devaux PE Aminophospholipid translocase and proteins involved in transmembrane phospholipid traffic
95. Lipid translocation across the plasma membrane of mammalian cells
96. ATP-dependent aminophospholipid translocation in erythrocyte vesicles: Stoichiometry of transport
97. Radioiodinated, photoactivatable phosphatidylcholine and phosphatidylserine: Transfer properties and differential photoreactive interaction with human erythrocyte membrane proteins
98. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry
99. Molecular cloning and protein structure of a human blood group Rh polypeptide
100. Null erythrocytes
101. Phosphatidylserine exposure and aminophospholipid translocase activity in Rh-deficient erythrocytes
102. 2+-ATPase: A candidate aminophospholipid translocase
103. 2+-ATPase activities from the human erythrocyte membrane
104. Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes
105. Identification and characterization of a candidate phosphatidylserine-transporting ATPase
106. Regulation of a candidate aminophospholipid-transporting ATPase by lipid
107. Purification and properties of a vanadate- and N-ethylmaleimide-sensitive ATPase from chromaffin granule membranes
108. Vanadate-sensitive ATPase from chromaffin granule membranes formed a phosphoenzyme intermediate and was activated by phosphatidylserine
109. Purification of a vanadate-sensitive ATPase from clathrin-coated vesicles of bovine brain
110. A subfamily of P-type ATPases with aminophospholipid transporting activity
111. Evolution of substrate specificities in the P-type ATPase superfamily
112. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae
113. Rapid transbilayer movement of fluorescent phospholipid analogues in the plasma membrane of endocytosis-deficient yeast cells does not require the Drs2 protein
114. Lipid specificity of the mouse ATPase II: A putative PS flippase
115. Cloning, expression, and chromosomal mapping of a human ATPase II gene, member of the third subfamily of P-type ATPases and orthologous to the presumed bovine and murine aminophospholipid translocase
116. Identification and functional expression of four isoforms of ATPase II, the putative aminophospholipid translocase
117. Chilling tolerance in Arabidopsis involves ALA1, a member of a new family of putative aminophospholipid translocases
118. ABC transporters in lipid transport
119. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
120. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
121. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
122. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein
123. Structure of MsbA from E. coli: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters
124. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane
125. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: Outward-directed transport by the multidrug resistance protein 1 (MRP1)
126. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane
127. Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes
128. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes
129. 2+-dependent transbilayer movement of phospholipid
130. Reconstitution of phospholipid scramblase activity from human blood platelets
131. 2+ accelerated transbilayer movement of membrane phospholipids
132. 2+ binding site
133. Unraveling the mysteries of phospholipid scrambling
134. Identification of three new members of the phospholipid scramblase gene family
135. 2+-induced phospholipid redistribution in the human erythrocyte membrane
136. 2+-induced loss of phospholipid asymmetry in the human erythrocyte: A study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling
137. Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells
138. Spectrin as a stabilizer of the phospholipid asymmetry in the human erythrocyte membrane
139. Interactions between membrane skeleton proteins and the intrinsic domain of the erythrocyte membrane
140. Red cell membrane abnormalities in chronic myeloid leukaemia
141. The interaction of spectrin-actin and synthetic phospholipids, II: The interaction with phosphatidylserine
142. Human erythrocyte protein 4.1 is a phosphatidylserine binding protein
143. Identification of the protein 4.1 binding site to phosphatidylserine vesicles
144. Stabilizing factors of phospholipid asymmetry in the erythrocyte-membrane
145. Membrane skeleton-bilayer interaction is not the major determinant of membrane phospholipid asymmetry in human erythrocytes
146. Human erythrocyte membrane lipid asymmetry: Transbilayer distribution of rapidly diffusing phosphatidylserines
147. Asymmetric distribution of phospholipids in spectrin-poor erythrocyte vesicles
148. Bilayer/cytoskeleton interactions in lipid-symmetric erythrocytes assessed by a photoactivable phospholipid analogue
149. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins
150. Is there any role of membrane bilayer-skeleton interaction in maintaining the transmembrane phospholipid asymmetry in erythrocytes?
151. Membrane-associated cytoskeleton and transbilayer phospholipid asymmetry
152. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
153. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
154. Phosphatidylserine, a death knell
155. Membrane phospholipid asymmetry and signal transduction
156. Early redistribution of plasma-membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus-inhibition by overexpression of Bc1-2 and Ab1
157. Induction of apoptosis by phosphatidylserine
158. Cell surface exposure of phosphatidylserine during apoptosis in phylogenetically conserved
159. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase
160. Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models
161. The recognition of red blood cells by macrophages: Role of phosphatidylserine and possible implications of membrane phospholipid asymmetry
162. Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages
163. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface
164. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
165. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages
166. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids
167. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts
168. A receptor for phosphatidylserine-specific clearance of apoptotic cells
169. Exposure of phosphatidylserine in the outer leaflet of human red blood cells
170. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia
171. Platelet aging in vivo is associated with loss of membrane phospholipid asymmetry
172. Membrane alterations in cellular aging: Susceptibility of phospholipids in density (age)-separated human erythrocytes to phospholipase A2
173. Generation of prothrombinconverting activity and the exposure of phosphatidylserine at the outer surface of platelets
174. Membrane phospholipid asymmetry as a factor in erythrocyte-endothelial cell interactions
175. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium
176. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombspondin
177. Increased erythrocyte phosphatidylserine exposure in chronic renal failure
178. Induction of ATP depletion, intramembrane particle aggregation and exposure of membrane phospholipids in chicken erythrocytes by local anesthetics and tranquilizers
179. Trinitrobenzenesulfonic acid and fluorodinitrobenzene: Probes to study local anesthetic effects in cell membranes
180. Bacterial cytotoxins, amphotericin B and local anesthetics enhance transbilayer mobility of phospholipids in erythrocyte membranes: Consequences for phospholipid asymmetry
181. Effect of benzyl alcohol on phospholipid transverse mobility in human erythrocyte membrane
182. Disturbing effect of cationic amphiphilic drugs on phospholipid asymmetry of the membrane lipid bilayer of human erythrocytes
183. Shape transformations induced by amphiphiles in erythrocytes
184. Devaux PE Influence of chlorpromazine on the transverse mobility of phospholipids in the human erythrocyte membrane: Relation to shape changes
185. Mechanisms of amphipath-induced stomatocytosis in human erythrocytes
186. Amphiphileinduced phosphatidylserine exposure in human erythrocytes
187. Acceleration of phospholipid flip-flop in the erythrocyte membrane by detergents differing in polar head group and alkyl chain length
188. Alcohols produce reversible and irreversible acceleration of phospholipid flip-flop in the human erythrocyte membrane
189. Protein-mediated transbilayer movement of lysophosphatidylcholine in glycophorin-containing vesicles
190. Glycophorin facilitates the transbilayer movement of phosphatidylcholine in vesicles
191. Lipid dependence of glycophorininduced transbilayer movement of lysophosphatidylcholine in large unilamellar vesicles
192. Glycophorin incorporation increases the bilayer permeability of large unilamellar vesicles in a lipid-dependent manner
193. Characterization of the permeability increase induced by the incorporation of glycophorin in phosphatidylcholine vesicles
194. Phospholipid distribution in human En(a-) red cell membranes which lack the major sialoglycoprotein, glycophorin A
195. The transbilayer movement of phosphatidylcholine in vesicles reconstituted with intrinsic proteins from the human erythrocyte membrane
196. The influence of lipid composition on the barrier properties of band 3-containing lipid vesicles
197. 5 induced flip-flop of phospholipids in sonicated vesicles
198. 5 on the transbilayer distribution of phospholipids in model membranes
199. Cytochrome P-450 facilitates phosphatidylcholine flip-flop in proteoliposomes
200. Exchangeability and rate of flip-flop of phosphatidylcholine in large unilamellar vesicles, cholate dialysis vesicles, and cytochrome oxidase vesicles
201. Membrane-spanning peptides induce phospholipid flop: A model for phospholipid translocation across the inner membrane of E. coli
202. Annexin V and vesicle membrane electroporation
203. Dielectric breakdown of the erythrocyte membrane enhances transbilayer mobility of phospholipids
204. Transbilayer reorientation of phospholipid probes in the human erythrocyte membrane: Lessons from studies on electroporated and resealed cells
205. Early stage shape change of human erythrocytes after application of electric field pulses
206. Electric field pulses induce reversible shape transformation of human erythrocytes
207. Passive transmembrane redistributions of phospholipids as a determinant of erythrocyte shape change: Studies on electroporated cells
208. Extensive electroporation abolishes experimentally induced shape transformations of erythrocytes: A consequence of phospholipid symmetrization?
209. Voltage-dependent lipid flip-flop induced by alamethicin
210. Pore-forming peptides induce rapid phospholipid flip-flop in membranes
211. Pore formation and translocation of melittin
212. Transbilayer transport of ions and lipids coupled with mastoparan X translocation
213. An antimicrobial peptide, magainin 2, induced rapid flipflop of phospholipids coupled with pore formation and peptide translocation
214. Magainins as paradigm for the mode of action of pore forming polypeptides
215. Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue
216. Generalised bilayer perturbation from peptide helix dimerisation at membrane surfaces: Vesicle lysis induced by disulphide-dimerised melittin analogues
217. Gramicidin-induced enhancement of transbilayer reorientation of lipids in the erythrocyte membrane
218. Lipid translocation across the human erythrocyte membrane
219. Complete exchange of phosphatidylcholine from intact erythrocytes after protein crosslinking
220. Cross-linking of SH-groups in the erythrocyte membrane enhances transbilayer reorientation of phospholipids: Evidence for a limited access of phospholipids to the reorientation sites
221. Effects of cross-linking of membrane components on cholesterol and phospholipid translocation
222. Accelerated interleaflet transport of phosphatidylcholine molecules in membranes under deformation
223. A polymeric "flippase" for surface-differentiated dipalmitoylphosphatidylcholine liposomes
224. Catalysis of transbilayer lipid migration by hydrophobically modified N-isopropylacrylamide polymers
225. Effect of pressure on phospholipid translocation in lipid bilayers
226. The influence of external surface potential and transmembrane potential on the passive transbilayer movement of phospholipids in the red blood cell membrane
227. Synthesis and complexation studies of neutral anion receptors
228. Facilitated phosphatidylcholine flip-flop across erythrocyte membranes using low-molecular-weight synthetic translocases
229. Facilitated phospholipid translocation across vesicle membranes using low-molecular-weight synthetic flippases
230. Selective phosphatidylethanolamine translocation across vesicle membranes using synthetic translocases
231. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor γ ligands and agonists
232. Lipid asymmetry induced by transmembrane pH gradients in large unilamellar vesicles
233. Phospholipid asymmetry in large unilamellar vesicles induced by transmembrane pH gradients
234. On the mechanism of transbilayer transport of phosphatidylglycerol in response to transmembrane pH gradients
235. Transbilayer transport of phosphatidic acid in response to transmembrane pH gradients
236. Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes
237. Mechanism of glucose-stimulated oxidation of human erythrocyte phospholipids
238. UVA irradiation induces energy-independent phospholipid-flip in mammalian plasma membrane